Safety Assessment Acute toxicity A single subcutaneous injection of AOD 9604 (50 mg/kg) did not cause death or obvious toxic reactions in mice
Q: What reconstitution solvent should I use
Last reviewed: June 8, 2026 Last updated: June 8, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
This 50mg research formulation is optimized for studies focusing on energy expenditure, sirtuin activation, and the reversal of diet-induced obesity in preclinical models
As with any injection, minor soreness at the injection site may occur
Key finding: AOD 9604 reduced body weight by 5.4 kg, reduced fasting glucose by 23 mg/dL, and improved HbA1c by 0.6%